(firstQuint)Long-term Safety and Efficacy of FURESTEM-CD Inj.

 in Patients With Moderately Active Crohn's Disease(CD).

 This study is an extended study of KSTHD_FURESTEM-CD phase 1 / 2a clinical trials in patients with moderate active Crohn's disease who had received at least once a FURESTEM-CD injection.

 The purpose of this clinical trial is to evaluate long-term safety and efficacy in patients for approximately 36 months (144 weeks).

.

 Long-term Safety and Efficacy of FURESTEM-CD Inj.

 in Patients With Moderately Active Crohn's Disease(CD)@highlight

The purpose of this clinical trial is to evaluate long-term safety and efficacy in patients who has history of FURESTEM-CD injection at least once.

